Table II.
Demographic | Limited by COVID-19 | OR/difference (95% CI) | p-value | |
---|---|---|---|---|
Yes (n = 50) | No (n = 53) | |||
Sex, n | OR 1.32 (0.29 to 1.39) | 0.251* | ||
Male | 18 | 25 | ||
Female | 32 | 28 | ||
Mean age, yrs (SD) | 68.3 (9.5) | 70.1 (10.8) | Diff 1.8 (-2.2 to 5.8) | 0.373† |
Mean BMI, kg/m2 (SD) | 30.6 (5.2) | 29.7 (6.7) | Diff 0.9 (-1.5 to 3.3) | 0.451† |
Comorbidity, n (% of group) | ||||
No disease | Reference | |||
Connect tissue | 7 | 8 | OR 1.09 (0.37 to 3.27) | 0.875* |
Diabetes | 9 | 6 | OR 0.58 (0.19 to 1.77) | 0.337* |
Back pain | 23 | 16 | OR 0.51 (0.23 to 1.14) | 0.098* |
Hypertension | 13 | 14 | OR 1.02 (0.42 to 2.46) | 0.962* |
Joint | OR 0.95 (0.44 to 2.07) | 0.896* | ||
THA | 22 | 24 | ||
TKA | 28 | 29 | ||
Mean functional measures (SD) | ||||
OHS (n = 46) | ||||
Preoperative | 18.6 (8.4) | 20.0 (7.7) | Diff 1.3 (-3.4 to 6.1) | 0.568† |
Postoperative | 33.8 (9.2) | 39.3 (10.1) | Diff 5.4 (-0.3 to 11.2) | 0.064† |
OKS (n = 57) | ||||
Preoperative | 18.8 (7.9) | 21.2 (7.2) | Diff 2.4 (-1.7 to 6.3) | 0.244† |
Postoperative | 30.8 (7.8) | 40.3 (6.2) | Diff 9.5 (5.8 to 13.3) | < 0.001† |
EQ-5D (n = 103) | ||||
Preoperative | 0.315 (0.316) | 0.392 (0.315) | Diff 0.077 (-0.046 to 0.201) | 0.216† |
Postoperative | 0.635 (0.226) | 0.833 (0.214) | Diff 0.198 (0.112 to 0.283) | < 0.001† |
Satisfied | OR 5.63 (1.15 to 27.52) | 0.019‡ | ||
Yes | 40 | 50 | ||
No | 9 | 2 | ||
Not answered | 1 | 1 |
Chi-squared test.
Independent-samples t-test.
Fisher's exact test
CI, confidence interval; EQ-5D, EuroQol five-dimension; N/A, not applicable; OHS, Oxford Hip Score; OKS, Oxford Knee Score; OR, odds ratio; SD, standard deviation; THA, total hip arthroplasty; TKA, total knee arthroplasty.